Holocene Advisors, LP Maxcyte, Inc. Transaction History

Holocene Advisors, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$4.03 - $5.89 $2.5 Million - $3.65 Million	-620,382 Reduced 22.66%	2,117,228 $10.5 Million
Q4 2022 Feb 14, 2023	SELL	$4.92 - $7.4 $1.5 Million - $2.25 Million	-304,350 Reduced 10.01%	2,737,610 $14.9 Million
Q2 2022 Aug 15, 2022	BUY	$3.59 - $6.81 $159,518 - $302,595	44,434 Added 1.48%	3,041,960 $14.4 Million
Q1 2022 May 16, 2022	BUY	$5.26 - $10.84 $119,738 - $246,761	22,764 Added 0.77%	2,997,526 $21 Million
Q4 2021 Feb 14, 2022	BUY	$8.87 - $12.94 $4.81 Million - $7.01 Million	542,040 Added 22.28%	2,974,762 $30.3 Million
Q3 2021 Nov 15, 2021	BUY	$12.21 - $17.2 $29.7 Million - $41.8 Million	2,432,722 New	2,432,722 $29.7 Million

124

65.6M

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $451M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

Get notified when there are updates to the investment portfolio of Holocene Advisors, LP, based on Form 13F filings with the SEC.

Stay updated on Holocene Advisors, LP with notifications on news.